Ms Laurita Burbach, LSCSW in Collyer, KS - Social Worker

Ms Laurita Burbach, LSCSW is a Social Worker - Clinical based in Collyer, Kansas. Ms Laurita Burbach is licensed to practice in Kansas (license number LSCSW 2226) and her current practice location is 22071 130 Ave, Collyer, Kansas. She can be reached at her office (for appointments etc.) via phone at (785) 769-3042.

NPI number for Ms Laurita Burbach is 1407027147 and her current mailing address is 22071 130 Ave, Collyer, Kansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1407027147.

Contact Information

	Ms Laurita Burbach, LSCSW
	22071 130 Ave, Collyer, KS 67631-6033
	(785) 769-3042
	Not Available

Healthcare Provider's Profile

Full Name	Ms Laurita Burbach
Gender	Female
Speciality	Social Worker - Clinical
Location	22071 130 Ave, Collyer, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1407027147
Provider Enumeration Date: 03/21/2008
Last Update Date: 03/21/2008

Medical Identifiers

Medical identifiers for Ms Laurita Burbach such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1407027147	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	LSCSW 2226 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Laurita Burbach is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Laurita Burbach, LSCSW 22071 130 Ave, Collyer, KS 67631-6033 Ph: (785) 769-3042	Ms Laurita Burbach, LSCSW 22071 130 Ave, Collyer, KS 67631-6033 Ph: (785) 769-3042

News Archive

Interim results from clinical trial demonstrate safety of cell-based therapy for retinitis pigmentosa

Regenerative medicine company jCyte and the Sue & Bill Gross Stem Cell Research Center at the University of California, Irvine report that their investigational therapy for retinitis pigmentosa (RP) has demonstrated a favorable safety and tolerability profile in an ongoing Phase I/II clinical trial.

Democrats should 'stand up strongly' for principles, columnist writes

If the Democrats gain control of at least one chamber of Congress, "the best thing that [they] can do, not just for their party and their country, but for the cause of bipartisanship, is ... stand up strongly for their principles," columnist Paul Krugman writes in a New York Times opinion piece.

Air quality in China improved during COVID lockdown

With the onset of COVID-19 in China, the government placed drastic restrictions on travel and work. This action led to a huge reduction in the number of vehicular movements and factories running. Now, a recent study published in the journal Science of The Total Environment in August 2020 shows this change had an unintended benefit – it cleared the air over northern China dramatically.

Simponi injection gets FDA approval to treat adults with ulcerative colitis

The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.

Genetic analysis of opioid-induced hyperalgesia

In findings published in Nature Biotechnology (May 2006, vol. 24 No. 5), Roche scientists present a new method for analyzing the metabolism of a commonly prescribed drug.

Ms Laurita Burbach, LSCSW - Clinical Social Worker in Collyer, KS